Close



Jan 3, 2024 06:00AM
Jan 3, 2024 06:00AM
Oct 27, 2023 01:50PM
Jul 26, 2023 12:31PM
Apr 20, 2023 08:10AM
Apr 20, 2023 08:00AM
Apr 5, 2023 06:55AM Eagle Pharmaceuticals (EGRX) reaches settlement with Dr. Reddy’s Laboratories on BENDEKA
Feb 27, 2023 06:01AM
Feb 27, 2023 06:00AM
Aug 5, 2022 09:17AM
Aug 5, 2022 02:41AM
Aug 4, 2022 05:56PM
Aug 4, 2022 05:50PM
Jul 29, 2022 01:24PM Dr. Reddy's Laboratories enters into a licensing agreement with Slayback Pharma to obtain exclusive rights in the first-to-file ANDA for the private label version of Lumify® in the U.S.
Jun 24, 2022 09:13AM
Jun 24, 2022 09:09AM
Apr 1, 2022 08:04AM
Apr 1, 2022 08:00AM
Apr 1, 2022 08:00AM
Feb 3, 2022 09:34AM
Feb 3, 2022 09:33AM Dr. Reddy's Laboratories Enters Into Definitive Agreement to Acquire German Medical Cannabis Firm Nimbus Health GmbH
Oct 14, 2021 08:00AM
Oct 5, 2021 12:42PM
Oct 5, 2021 08:46AM
Oct 5, 2021 08:45AM
Sep 7, 2021 07:34AM
Sep 7, 2021 07:30AM
May 13, 2021 03:21AM Pregene and Dr. Reddy's Announce License Agreement for Anti-BCMA CAR-T PRG1801 in India
Dec 7, 2020 08:08AM
Dec 7, 2020 08:00AM
Nov 28, 2020 11:33AM
Oct 9, 2020 06:09AM
Oct 9, 2020 03:02AM
Jul 29, 2020 06:47AM
Jun 10, 2020 05:49AM Dr. Reddy’s Laboratories Completes the Acquisition of Select Business Divisions of Wockhardt
Feb 12, 2020 05:58AM
Feb 12, 2020 02:56AM
Jul 31, 2019 04:05PM
Jul 20, 2019 06:22AM
Jun 13, 2019 11:57PM
Apr 13, 2019 12:34PM
Apr 2, 2019 10:48AM Encore Dermatology Inc. Acquires SERNIVO®, TRIANEX® and PROMISEB®
Oct 15, 2018 12:48AM
Oct 2, 2018 04:59AM
Oct 1, 2018 01:36AM
Jun 15, 2018 12:02PM
Jun 15, 2018 12:00PM
Jun 14, 2018 11:06PM
Aug 30, 2017 04:14PM VIVUS (VVUS) Settles with Dr. Reddy's Laboratories on Qsymia Patent Litigation
Aug 28, 2017 08:45AM

921,809 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All